[ad_1]
The current ratio of AxoGen, Inc. (NasdaqCM: AXGN) is 3.32. The current ratio is used by investors to determine whether a company can pay short-term and long-term debt. The current ratio is for all liquid and non-liquid badets relative to total current liabilities of the Company. A high capital ratio indicates that the company has little difficulty managing its working capital. A low liquidity ratio (when short-term liabilities are higher than current badets) indicates that the company may have difficulty paying its short-term obligations.
Investors always strive to make better decisions. There are so many options available, and this can make things more complex. Starting with a solid approach can help ease the initial incursion of the investor into the stock market. Accumulating market knowledge can take a lot of time and effort. Many investors can discover the hard way that there is no easy way to beat the markets. Many investors are teased with investment tips from friends or co – workers. It can be very tempting to take advice from someone who has already proven himself by beating the market. However, the old saying remains the same; past results may not indicate future results. Investors may find that doing their own research can provide a huge boost to the portfolio's performance.
Volatility & Price
Market volatility is a percentage that indicates whether a stock is a desirable purchase. Investors are looking at Volatility 12m to determine whether a company has a low percentage of volatility or not during a year. The 12m volatility of AxoGen, Inc. (NasdaqCM: AXGN) is 40.9886. This is calculated by taking the weekly normal log yields and the standard deviation of the price of the stock over an annualized year. The lower the number, the lower the volatility. Volatility 3m is a similar percentage determined by the daily normal daily yields and the standard deviation of the price of the stock over 3 months. The 3m volatility of AxoGen, Inc. (NasdaqCM: AXGN) is 38.5909. The 6m volatility is the same except measured over a six month period. The 6m Volatility is 47.3994.
We can now take a look at some historical data from the stock index. AxoGen, Inc. (NasdaqCM: AXGN) currently has a 10-month price index of 3.18328. The price index is calculated by dividing the current price of the stock by the stock price ten months ago. A ratio greater than one indicates an increase in the stock price during the period. A ratio below one shows that the price has decreased during this period. Looking at other periods, the 12-month price index is 3.26733, the 24-month is 8.08824, and the 36-month is 15.37267. Getting closer a bit, the 5 month price index is 1.80657, the three month month is 1.30779 and the month of 1.12628.
The Leverage Ratio of AxoGen, Inc. (NasdaqCM: AXGN) is 0.499472. Leverage ratio is the total debt of a company divided by the total badets of the current year and the past year divided by two. Companies are indebted to finance their daily operations. The leverage ratio can measure a company's share of capital that comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long-term and short-term financial obligations.
C-Score
AxoGen, Inc. (NasdaqCM: AXGN) currently has a Montier C-score of 2. This indicator was developed by James Montier in order to identify companies that Cooked books to better appear on paper. The score ranges from zero to six where a 0 would indicate no proof of book firing, and a 6 would indicate a high probability. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six entries in the calculation. These data included a growing difference between net income and cash flow from operations, the increase in debtor days, higher inventory sales, the increase in other current badets, the decline in the depreciation in relation to gross property, plant and equipment. F Score, ERP5 and Magic Formula
The Piotroski F-Score is a rating system between 1 and 9 that determines the financial strength of a company. The score helps to determine if the stock of a company is valuable or not. The Piotroski F-score of AxoGen, Inc. (NasdaqCM: AXGN) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated based on the return on badets (ROA), the return on liquid badets (CFROA), the change in return on badets and the quality of profits. It is also calculated based on the evolution of the debt ratio or the leverage effect, the liquidity and the variation of the shares outstanding. The score is also determined by the change in the gross margin and the change in the turnover of the badets.
Rank ERP5 is an investment tool that badysts use to discover undervalued companies. The ERP5 focuses on the price-to-book ratio, the return on earnings, the ROCE and the average ROCE over five years. The ERP5 of AxoGen, Inc. (NasdaqCM: AXGN) is 15731. The lower the ERP5 rank, the more the company is undervalued. The MF ranking (aka magic formula) is a formula that identifies a valuable company at a good price. The formula is calculated by looking at companies that have a high return on income as well as a high return on investment. The AxoGen, Inc. (NasdaqCM: AXGN) MF rating is 13734. A low ranking company is considered a good company in which to invest. The magic formula was introduced in a book written by Joel Greenblatt, entitled "The little book that beats the market".
Return of the Shareholder
The Qi The value of AxoGen, Inc. (NasdaqCM: AXGN) is 61. The Qi Value is a useful tool for determining whether a business is undervalued or not. Q.i.The value is calculated using the following ratios: EBITDA Return, Earnings Return, FCF Return and Liquidity. The lower the Q.i. value, the more the business is undervalued. Value Composite One (VC1) is a method that investors use to determine the value of a business. The VC1 of AxoGen, Inc. (NasdaqCM: AXGN) is 84. A company with a value of 0 is considered an undervalued company, while a company with a value of 100 is considered a overvalued society. VC1 is calculated using the book value, sales price, EV EBITDA, cash flow price, and profit price. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Return. The composite value of two of AxoGen, Inc. (NasdaqCM: AXGN) is 84.
Source link
